Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9538841 | 0.96 | LMNA (0.44) | LMNATHRB | |
| SCHEMBL896585 | 0.96 | LMNA (0.37) | LMNATHRB | |
| SCHEMBL9538354 | 0.96 | LMNA (0.44) | LMNATHRB | |
| SCHEMBL10534900 | 0.93 | LMNA (0.35) | LMNA | |
| SCHEMBL4977272 | 0.92 | LMNA (0.32) | LMNA | |
| SCHEMBL9538166 | 0.91 | — | — | |
| SCHEMBL9535929 | 0.88 | LMNA (0.37) | LMNATHRB | |
| SCHEMBL10381191 | 0.88 | LMNA (0.37) | LMNATHRB | |
| SCHEMBL758679 | 0.87 | LMNA (0.33) | LMNA | |
| SCHEMBL8060577 | 0.87 | LMNA (0.33) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3759213-B1 | METHODS, COMPOSITIONS, AND DEVICES FOR ISOLATION AND EXPRESSION ANALYSIS OF REGIONS OF INTEREST FROM A TISSUE | QUANTUMCYTE INC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4720212-A1 | SAFEGUARD AGENT AND USE THEREOF | Li, Haibo (CN) | 2026-04-08 | — | — | EP | claimed |
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| WO-2025091685-A1 | FLUORINATED LIQUID COMPOSITION AND USE THEREOF | 深圳市鸿富诚新材料股份有限公司 | 2025-05-08 | — | — | WO | claimed |
| US-12227789-B2 | Methods, compositions, and devices for isolation and expression analysis of regions of interest from a tissue | QUANTUMCYTE, INC. (US) | 2025-02-18 | — | — | US | claimed |
| CN-119056001-A | Preparation method and application of dry water-like material and method for preparing composite particle material by using dry water-like material | 中国民航大学 | 2024-12-03 | — | — | CN | claimed |
| US-20240390719-A1 | SAFEGUARD AGENT AND USE THEREOF | LI HAIBO (CN) | 2024-11-28 | — | — | US | claimed |
| WO-2024240215-A1 | SAFEGUARD AGENT AND USE THEREOF | LI HAIBO (CN) | 2024-11-28 | — | — | WO | claimed |
| CN-117603661-A | Fluorinated liquid composition and application thereof | 武汉肯达科讯科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117442922-A | Ultralow temperature-reducing fire extinguishing agent based on low-boiling-point gas fire extinguishing agent, and preparation method and application thereof | 中国民航大学 | 2024-01-26 | — | — | CN | claimed |
| US-7824436-B2 | Methods and devices for non-invasive cerebral and systemic cooling | BENECHILL, INC. (US) | 2010-11-02 | — | — | US | claimed |
| EP-1888156-A2 | METHODS AND DEVICES FOR NON-INVASIVE CEREBRAL AND SYSTEMIC COOLING | Benechill, Inc. (US) | 2008-02-20 | — | — | EP | claimed |
| WO-2006124702-A2 | METHODS AND DEVICES FOR NON-INVASIVE CEREBRAL AND SYSTEMIC COOLING | BENECHILL, INC. (US) | 2006-11-23 | — | — | WO | claimed |
| EP-0921109-B1 | METHOD FOR PURIFYING 1,1,1,3,3-PENTAFLUOROPROPANE | DAIKIN IND LTD (JP) | 2002-01-23 | — | — | EP | claimed |
| US-6191328-B1 | EXTRACTION; PURIFICATION | DAIKIN INDUSTRIES, LTD. (JP) | 2001-02-20 | — | — | US | claimed |
| EP-0921109-A1 | METHOD FOR PURIFYING 1,1,1,3,3-PENTAFLUOROPROPANE | DAIKIN INDUSTRIES, LIMITED (JP) | 1999-06-09 | — | — | EP | claimed |
| WO-1999024016-A1 | EMULSIONS FOR AEROSOLIZATION AND DRUG DELIVERY | SONUS PHARMACEUTICALS, INC. (US) | 1999-05-20 | — | — | WO | claimed |
| EP-0830436-A1 | REFRIGERANTS BASED ON HYDROFLUOROETHER OF FLUOROETHER | E.I. DU PONT DE NEMOURS & CO. (INC.) (US) | 1998-03-25 | — | — | EP | claimed |
| WO-1996040834-A1 | REFRIGERANTS BASED ON HYDROFLUOROETHER OF FLUOROETHER | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-12-19 | — | — | WO | claimed |
| US-5073290-A | Compositions of 1,1,1,2,2,5,5,5-octafluoro-4-trifluormethypentane and use thereof for cleaning solid surfaces | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-12-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240390719-A1 | SAFEGUARD AGENT AND USE THEREOF | BAX, CASP8, BCL2 | LMNA 2980/4885THRB 1883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.